Clinical Trial Update: S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED) [Phase 2]

View source ↗

Summary

Phase 2 trial S0224 evaluating docetaxel for locally advanced or metastatic penile cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Penile Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Penile Cancer | Phase 2 | Status: TERMINATED